Broadening INPP5E phenotypic spectrum: detection of rare variants in syndromic and non-syndromic IRD.


Journal

NPJ genomic medicine
ISSN: 2056-7944
Titre abrégé: NPJ Genom Med
Pays: England
ID NLM: 101685193

Informations de publication

Date de publication:
29 Jun 2021
Historique:
received: 18 12 2020
accepted: 21 05 2021
entrez: 30 6 2021
pubmed: 1 7 2021
medline: 1 7 2021
Statut: epublish

Résumé

Pathogenic variants in INPP5E cause Joubert syndrome (JBTS), a ciliopathy with retinal involvement. However, despite sporadic cases in large cohort sequencing studies, a clear association with non-syndromic inherited retinal degenerations (IRDs) has not been made. We validate this association by reporting 16 non-syndromic IRD patients from ten families with bi-allelic mutations in INPP5E. Additional two patients showed early onset IRD with limited JBTS features. Detailed phenotypic description for all probands is presented. We report 14 rare INPP5E variants, 12 of which have not been reported in previous studies. We present tertiary protein modeling and analyze all INPP5E variants for deleteriousness and phenotypic correlation. We observe that the combined impact of INPP5E variants in JBTS and non-syndromic IRD patients does not reveal a clear genotype-phenotype correlation, suggesting the involvement of genetic modifiers. Our study cements the wide phenotypic spectrum of INPP5E disease, adding proof that sequence defects in this gene can lead to early-onset non-syndromic IRD.

Identifiants

pubmed: 34188062
doi: 10.1038/s41525-021-00214-8
pii: 10.1038/s41525-021-00214-8
pmc: PMC8242099
doi:

Types de publication

Journal Article

Langues

eng

Pagination

53

Subventions

Organisme : NEI NIH HHS
ID : R01 EY026904
Pays : United States
Organisme : NICHD NIH HHS
ID : P50 HD105351
Pays : United States
Organisme : U.S. Department of Health & Human Services | NIH | National Eye Institute (NEI)
ID : R01EY012910
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation)
ID : 31003A_176097
Organisme : Foundation Fighting Blindness (Foundation Fighting Blindness, Inc.)
ID : BR-GE-0214-0639-TECH
Organisme : NEI NIH HHS
ID : R01 EY012910
Pays : United States
Organisme : Foundation Fighting Blindness (Foundation Fighting Blindness, Inc.)
ID : EGI-GE-1218-0753-UCSD
Organisme : NEI NIH HHS
ID : P30 EY014104
Pays : United States
Organisme : Foundation Fighting Blindness (FFB)
ID : BR-GE-0214-0639-TECH

Références

Daiger S. P., Sullivan L. S., Bowne S. J., R. B. RetNet. Retinal Information Network. https://sph.uth.edu/retnet/ .
Hildebrandt, F., Benzing, T. & Katsanis, N. Ciliopathies. N. Engl. J. Med. 364, 1533–1543 (2011).
pubmed: 21506742 pmcid: 3640822 doi: 10.1056/NEJMra1010172
Wheway, G., Nazlamova, L. & Hancock, J. T. Signaling through the primary cilium. Front. Cell Dev. Biol. 6, 8 (2018).
pubmed: 29473038 pmcid: 5809511 doi: 10.3389/fcell.2018.00008
Bujakowska, K. M., Liu, Q. & Pierce, E. A. Photoreceptor cilia and retinal ciliopathies. Cold Spring Harb. Perspect. Biol. 9, a028274 (2017).
pubmed: 28289063 pmcid: 5629997 doi: 10.1101/cshperspect.a028274
Chen, H. Y., Kelley, R. A., Li, T. & Swaroop, A. Primary cilia biogenesis and associated retinal ciliopathies. Semin. Cell Dev. Biol. 110, 70–88 (2021).
pubmed: 32747192 doi: 10.1016/j.semcdb.2020.07.013
Maria, B. L. et al. ‘Joubert syndrome’ revisited: key ocular motor signs with magnetic resonance imaging correlation. J. Child Neurol. 12, 423–430 (1997).
pubmed: 9373798 doi: 10.1177/088307389701200703
Brancati, F., Dallapiccola, B. & Valente, E. M. Joubert Syndrome and related disorders. Orphanet J. Rare Dis. 5, 1–10 (2010).
doi: 10.1186/1750-1172-5-20
The Genotype-Tissue Expression (GTEx) Project. www.gtexportal.org .
Jacoby, M. et al. INPP5E mutations cause primary cilium signaling defects, ciliary instability and ciliopathies in human and mouse. Nat. Genet. 41, 1027–1031 (2009).
pubmed: 19668215 doi: 10.1038/ng.427
Bielas, S. L. et al. Mutations in INPP5E, encoding inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol signaling to the ciliopathies. Nat. Genet. 41, 1032–1036 (2009).
pubmed: 19668216 pmcid: 2746682 doi: 10.1038/ng.423
Stone, E. M. et al. Clinically focused molecular investigation of 1000 consecutive families with inherited retinal disease. Ophthalmology 124, 1314–1331 (2017).
pubmed: 28559085 doi: 10.1016/j.ophtha.2017.04.008
Brooks, B. P. et al. Joubert syndrome: ophthalmological findings in correlation with genotype and hepatorenal disease in 99 patients prospectively evaluated at a single center. Ophthalmology 125, 1937–1952 (2018).
pubmed: 30055837 doi: 10.1016/j.ophtha.2018.05.026
Toma, C. et al. Macular staphyloma in patients affected by Joubert syndrome with retinal dystrophy: a new finding detected by SD-OCT. Doc. Ophthalmol. 137, 25–36 (2018).
pubmed: 29987673 doi: 10.1007/s10633-018-9646-x
Fadaie, Z. et al. Identification of splice defects due to non-canonical splice site or deep-intronic variants in ABCA4. Hum. Mutat. 40, 2365–2376 (2019).
pubmed: 31397521 pmcid: 6899986 doi: 10.1002/humu.23890
Radha Rama Devi, A., Naushad, S. M. & Lingappa, L. Clinical and molecular diagnosis of Joubert syndrome and related disorders. Pediatr. Neurol. 106, 43–49 (2020).
pubmed: 32139166 doi: 10.1016/j.pediatrneurol.2020.01.012
Travaglini, L. et al. Phenotypic spectrum and prevalence of INPP5E mutations in Joubert Syndrome and related disorders. Eur. J. Hum. Genet. 21, 1074–1078 (2013).
pubmed: 23386033 pmcid: 3778343 doi: 10.1038/ejhg.2012.305
Tsurusaki, Y. et al. The diagnostic utility of exome sequencing in Joubert syndrome and related disorders. J. Hum. Genet. 58, 113–115 (2013).
pubmed: 23034536 doi: 10.1038/jhg.2012.117
Sönmez, F. et al. Development of end-stage renal disease at a young age in two cases with Joubert syndrome. Turk. J. Pediatr. 56, 458–461 (2014).
pubmed: 25818971
Kroes, H. Y. et al. Joubert syndrome: genotyping a Northern European patient cohort. Eur. J. Hum. Genet. 24, 214–220 (2016).
pubmed: 25920555 doi: 10.1038/ejhg.2015.84
Suzuki, T. et al. Molecular genetic analysis of 30 families with Joubert syndrome. Clin. Genet. 90, 526–535 (2016).
pubmed: 27434533 doi: 10.1111/cge.12836
De Goede, C. et al. Role of reverse phenotyping in interpretation of next generation sequencing data and a review of INPP5E related disorders. Eur. J. Paediatr. Neurol. 20, 286–295 (2016).
pubmed: 26748598 doi: 10.1016/j.ejpn.2015.11.012
Hardee, I. et al. Defective ciliogenesis in INPP5E-related Joubert syndrome. Am. J. Med. Genet. Part A 173, 3231–3237 (2017).
pubmed: 29052317 doi: 10.1002/ajmg.a.38376
Shetty, M., Ramdas, N., Sahni, S., Mullapudi, N. & Hegde, S. A homozygous missense variant in INPP5E associated with Joubert syndrome and related disorders. Mol. Syndromol. 8, 313–317 (2017).
pubmed: 29230161 pmcid: 5701266 doi: 10.1159/000479673
Wang, X. et al. Comprehensive molecular diagnosis of 179 Leber congenital amaurosis and juvenile retinitis pigmentosa patients by targeted next generation sequencing. J. Med. Genet. 50, 674–688 (2013).
pubmed: 23847139 doi: 10.1136/jmedgenet-2013-101558
Xu, Y. et al. Mutation analysis in 129 genes associated with other forms of retinal dystrophy in 157 families with retinitis pigmentosa based on exome sequencing. Mol. Vis. 21, 477–486 (2015).
pubmed: 25999675 pmcid: 4415588
Birtel, J. et al. Clinical and genetic characteristics of 251 consecutive patients with macular and cone/cone-rod dystrophy. Sci. Rep. 8, 4824 (2018).
pubmed: 29555955 pmcid: 5859282 doi: 10.1038/s41598-018-22096-0
Genome Aggregation Database (GnomAD). https://gnomad.broadinstitute.org .
Davydov, E. V. et al. Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLoS Comput. Biol. 6, e1001025 (2010).
pubmed: 21152010 pmcid: 2996323 doi: 10.1371/journal.pcbi.1001025
Kumar, P., Henikoff, S. & Ng, P. C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4, 1073–1081 (2009).
pubmed: 19561590 doi: 10.1038/nprot.2009.86
Adzhubei, I., Jordan, D. M. & Sunyaev, S. R. Predicting functional effect of human missense mutations using PolyPhen-2. Curr. Protoc. Hum. Genet. https://doi.org/10.1002/0471142905.hg0720s76 (2013).
doi: 10.1002/0471142905.hg0720s76 pubmed: 23315928 pmcid: 4480630
Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J. & Kircher, M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 47, D886–D894 (2019).
pubmed: 30371827 doi: 10.1093/nar/gky1016
O’Brien, P. J., Lassila, J. K., Fenn, T. D., Zalatan, J. G. & Herschlag, D. Arginine coordination in enzymatic phosphoryl transfer: Evaluation of the effect of Arg166 mutations in Escherichia coli alkaline phosphatase. Biochemistry 47, 7663–7672 (2008).
pubmed: 18627128 doi: 10.1021/bi800545n
Yates, C. M., Filippis, I., Kelley, L. A. & Sternberg, M. J. E. SuSPect: enhanced prediction of single amino acid variant (SAV) phenotype using network features. J. Mol. Biol. 426, 2692–2701 (2014).
pubmed: 24810707 pmcid: 4087249 doi: 10.1016/j.jmb.2014.04.026
Khan, S. et al. BBS5 and INPP5E mutations associated with ciliopathy disorders in families from Pakistan. Ann. Hum. Genet. 83, 477–482 (2019).
pubmed: 31173343 doi: 10.1111/ahg.12336
Lopez, E. et al. C5orf42 is the major gene responsible for OFD syndrome type VI. Hum. Genet. 133, 367–377 (2014).
pubmed: 24178751 doi: 10.1007/s00439-013-1385-1
Date, H. et al. Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene. Nat. Genet. 29, 184–188 (2001).
pubmed: 11586299 doi: 10.1038/ng1001-184
Moreira, M. C. et al. The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin. Nat. Genet. 29, 189–193 (2001).
pubmed: 11586300 doi: 10.1038/ng1001-189
Alkanderi, S. et al. ARL3 mutations cause Joubert syndrome by disrupting ciliary protein composition. Am. J. Hum. Genet. 103, 612–620 (2018).
pubmed: 30269812 pmcid: 6174286 doi: 10.1016/j.ajhg.2018.08.015
Han, S. et al. TULP3 is required for localization of membrane-associated proteins ARL13B and INPP5E to primary cilia. Biochem. Biophys. Res. Commun. 509, 227–234 (2019).
pubmed: 30583862 doi: 10.1016/j.bbrc.2018.12.109
Kousi, M. & Katsanis, N. Genetic modifiers and oligogenic inheritance. Cold Spring Harb. Perspect. Med. 5, a017145 (2015).
pubmed: 26033081 pmcid: 4448705 doi: 10.1101/cshperspect.a017145
Louie, C. M. et al. AHI1 is required for photoreceptor outer segment development and is a modifier for retinal degeneration in nephronophthisis. Nat. Genet. 42, 175–180 (2010).
pubmed: 20081859 pmcid: 2884967 doi: 10.1038/ng.519
Davis, E. E. et al. TTC21B contributes both causal and modifying alleles across the ciliopathy spectrum. Nat. Genet. 43, 189–196 (2011).
pubmed: 21258341 pmcid: 3071301 doi: 10.1038/ng.756
Scott, H. A. et al. Expanding the phenotypic spectrum in RDH12-associated retinal disease. Cold Spring Harb. Mol. case Stud. 6, a004754 (2020).
pubmed: 32014858 pmcid: 6996522 doi: 10.1101/mcs.a004754
Moye, A. R. et al. Mutations in ARL2BP, a protein required for ciliary microtubule structure, cause syndromic male infertility in humans and mice. PLoS Genet. 15, e1008315 (2019).
pubmed: 31425546 pmcid: 6715254 doi: 10.1371/journal.pgen.1008315
Haer-Wigman, L. et al. Non-syndromic retinitis pigmentosa due to mutations in the mucopolysaccharidosis type IIIC gene, heparan-alpha-glucosaminide N-acetyltransferase (HGSNAT). Hum. Mol. Genet. 24, 3742–3751 (2015).
pubmed: 25859010 pmcid: 4459392
Men, C. J. et al. The importance of genetic testing as demonstrated by two cases of CACNA1F-associated retinal generation misdiagnosed as LCA. Mol. Vis. 23, 695–706 (2017).
pubmed: 29062221 pmcid: 5640518
Consugar, M. B. et al. Panel-based genetic diagnostic testing for inherited eye diseases is highly accurate and reproducible, and more sensitive for variant detection, than exome sequencing. Genet Med. 17, 253–261 (2015).
pubmed: 25412400 doi: 10.1038/gim.2014.172
McKenna, A. et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297–1303 (2010).
pubmed: 20644199 pmcid: 2928508 doi: 10.1101/gr.107524.110
McLaren, W. et al. The ensembl variant effect predictor. Genome Biol. 17, 122 (2016).
pubmed: 27268795 pmcid: 4893825 doi: 10.1186/s13059-016-0974-4
Farkas, M. H. et al. Transcriptome analyses of the human retina identify unprecedented transcript diversity and 3.5 Mb of novel transcribed sequence via significant alternative splicing and novel genes. BMC Genomics 14, 486 (2013).
pubmed: 23865674 pmcid: 3924432 doi: 10.1186/1471-2164-14-486
Zampaglione, E. et al. Copy-number variation contributes 9% of pathogenicity in the inherited retinal degenerations. Genet. Med. 22, 1079–1087 (2020).
pubmed: 32037395 pmcid: 7272325 doi: 10.1038/s41436-020-0759-8
Pedersen, B. S. & Quinlan, A. R. Who’s who? Detecting and resolving sample anomalies in human DNA sequencing studies with Peddy. Am. J. Hum. Genet. 100, 406–413 (2017).
pubmed: 28190455 pmcid: 5339084 doi: 10.1016/j.ajhg.2017.01.017
Sharon, D. et al. A nationwide genetic analysis of inherited retinal diseases in Israel as assessed by the Israeli inherited retinal disease consortium (IIRDC). Hum. Mutat. 41, 140–149 (2020).
pubmed: 31456290 doi: 10.1002/humu.23903
Peter, V. G. et al. The Liberfarb syndrome, a multisystem disorder affecting eye, ear, bone, and brain development, is caused by a founder pathogenic variant in thePISD gene. Genet. Med. 21, 2734–2743 (2019).
pubmed: 31263216 pmcid: 6892740 doi: 10.1038/s41436-019-0595-x
Taylor, R. L. et al. Association of steroid 5α-reductase type 3 congenital disorder of glycosylation with early-onset retinal dystrophy. JAMA Ophthalmol. 135, 339–347 (2017).
pubmed: 28253385 doi: 10.1001/jamaophthalmol.2017.0046
Chen, X. et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. Bioinformatics 32, 1220–1222 (2016).
pubmed: 26647377 doi: 10.1093/bioinformatics/btv710
Roller, E., Ivakhno, S., Lee, S., Royce, T. & Tanner, S. Canvas: versatile and scalable detection of copy number variants. Bioinformatics 32, 2375–2377 (2016).
pubmed: 27153601 doi: 10.1093/bioinformatics/btw163
Madeira, F. et al. The EMBL-EBI search and sequence analysis tools APIs in 2019. Nucleic Acids Res. 47, W636–W641 (2019).
pubmed: 30976793 pmcid: 6602479 doi: 10.1093/nar/gkz268
Bateman, A. et al. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 49, D480–D489 (2021).
doi: 10.1093/nar/gkaa1100
Wiel, L. et al. MetaDome: pathogenicity analysis of genetic variants through aggregation of homologous human protein domains. Hum. Mutat. 40, 1030–1038 (2019).
pubmed: 31116477 pmcid: 6772141
Ittisoponpisan, S. et al. Can predicted protein 3D structures provide reliable insights into whether missense variants are disease associated? J. Mol. Biol. 431, 2197–2212 (2019).
pubmed: 30995449 pmcid: 6544567 doi: 10.1016/j.jmb.2019.04.009
Blom, N., Gammeltoft, S. & Brunak, S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol. 294, 1351–1361 (1999).
pubmed: 10600390 doi: 10.1006/jmbi.1999.3310

Auteurs

Riccardo Sangermano (R)

Ocular Genomics Institute, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.

Iris Deitch (I)

Retina Service, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.

Virginie G Peter (VG)

Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland.
Department of Ophthalmology, University of Basel, Basel, Switzerland.
Experimental Pathology, Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland.

Rola Ba-Abbad (R)

Genetics Service, Moorfields Eye Hospital, London, UK.
UCL Institute of Ophthalmology, University College London, London, UK.

Emily M Place (EM)

Ocular Genomics Institute, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.

Erin Zampaglione (E)

Ocular Genomics Institute, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.

Naomi E Wagner (NE)

Ocular Genomics Institute, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.

Anne B Fulton (AB)

Department of Ophthalmology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.

Luisa Coutinho-Santos (L)

Department of Ophthalmology, Instituto de Oftalmologia Dr. Gama Pinto, Lisbon, Portugal.

Boris Rosin (B)

Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

Vincent Dunet (V)

Department of Diagnostic and Interventional Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Ala'a AlTalbishi (A)

Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
St. John Eye Hospital, Jerusalem, Israel.

Eyal Banin (E)

Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

Ana Berta Sousa (AB)

Department of Medical Genetics, Hospital Santa Maria, Centro Hospitalar Universitário Lisboa Norte (CHULN), Lisbon Academic Medical Center (CAML), Lisbon, Portugal.

Mariana Neves (M)

Department of Medical Genetics, Hospital Santa Maria, Centro Hospitalar Universitário Lisboa Norte (CHULN), Lisbon Academic Medical Center (CAML), Lisbon, Portugal.

Anna Larson (A)

Ocular Genomics Institute, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.

Mathieu Quinodoz (M)

Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland.
Department of Ophthalmology, University of Basel, Basel, Switzerland.
Department of Genetics and Genome Biology, University of Leicester, Leicester, UK.

Michel Michaelides (M)

Genetics Service, Moorfields Eye Hospital, London, UK.
UCL Institute of Ophthalmology, University College London, London, UK.

Tamar Ben-Yosef (T)

Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Eric A Pierce (EA)

Ocular Genomics Institute, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.

Carlo Rivolta (C)

Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland.
Department of Ophthalmology, University of Basel, Basel, Switzerland.
Department of Genetics and Genome Biology, University of Leicester, Leicester, UK.

Andrew R Webster (AR)

Genetics Service, Moorfields Eye Hospital, London, UK.
UCL Institute of Ophthalmology, University College London, London, UK.

Gavin Arno (G)

Genetics Service, Moorfields Eye Hospital, London, UK.
UCL Institute of Ophthalmology, University College London, London, UK.

Dror Sharon (D)

Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

Rachel M Huckfeldt (RM)

Ocular Genomics Institute, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA. Rachel_Huckfeldt@MEEI.HARVARD.EDU.

Kinga M Bujakowska (KM)

Ocular Genomics Institute, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA. kinga_bujakowska@meei.harvard.edu.

Classifications MeSH